Jian Yang

Dr. Jian Yang

Shanghai University, Shanghai, China
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HRHimanshu Rai
Himanshu Rai
SGSarika Gupta
Sarika Gupta
SKSaroj Kumar
Saroj Kumar
Jian YangJian Yang
Jian Yang
SSSingh Kumar Singh
Singh Kumar Singh
GMGyan Modi
Gyan Modi

26 November 2019 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
Jian YangJian Yang
Jian Yang
FZFantian Zeng
Fantian Zeng
YGYiran Ge
Yiran Ge
KPKewen Peng
Kewen Peng
XLXiaofang Li
Xiaofang Li
JDJi Dezhong
Ji Dezhong

7 December 2019 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
Jian YangJian Yang
Jian Yang
FZFantian Zeng
Fantian Zeng
XLXiaofang Li
Xiaofang Li
CRChongzhao Ran
Chongzhao Ran
JDJi Dezhong
Ji Dezhong
YLYuyan Li
Yuyan Li
In this report, we demonstrate a “V-shaped” NIRF probe PTO-29, which can monitor Aβ oligomers with high selectivity. PTO-29 was designed and showed significant response to Aβ oligomers in the fluorescence spectral tests and good properties. In vivo imaging results indicate that 4 month APP/PS1 AD mice have higher signals in the brain than age-matched wild type mice.

19 July 2021 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
FZFantian Zeng
Fantian Zeng
KPKewen Peng
Kewen Peng
LHLing Han
Ling Han
Jian YangJian Yang
Jian Yang

17 June 2022 in Molecules
Verified
Journal Article
Open access
PDF file
HYHaijun Yang
Haijun Yang
FZFantian Zeng
Fantian Zeng
YLyunchun luo
yunchun luo
CZChao Zheng
Chao Zheng
CRChongzhao Ran
Chongzhao Ran
Jian YangJian Yang
Jian Yang
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders, which is caused by multi-factors and characterized by two histopathological hallmarks: amyloid-β (Aβ) plaques and neurofibrillary tangles of Tau proteins. Thus, researchers have been devoting tremendous efforts to developing and designing new molecules for the early diagnosis of AD and curative purposes. Curcumin and its scaffold have fluorescent and photochemical properties. Mounting evidence showed that curcumin scaffold had neuroprotective effects on AD such as anti-amyloidogenic, anti-inflammatory, anti-oxidative and metal chelating. In this review, we summarized different curcumin derivatives and analyzed the in vitro and in vivo results in order to exhibit the applications in AD diagnosis, therapeutic monitoring and therapy. The analysis results showed that, although curcumin and its analogues have some disadvantages such as short wavelength and low bioavailability, these shortcomings can be conquered by modifying the structures. Curcumin scaffold still has the potential to be a multifunctional tool for AD research, including AD diagnosis and therapy.
1

14 September 2021 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
YGYiran Ge
Yiran Ge
FZFantian Zeng
Fantian Zeng
GSGaofeng Sun
Gaofeng Sun
KPKewen Peng
Kewen Peng
XLXiao Li
Xiao Li
Jian YangJian Yang
Jian Yang